| Previous Close | 53.12 |
|---|---|
| Volume | 19,443 |
| Day's Range | 52.82 - 53.38 |
| 52-Week Range | 35.57 - 54.75 |
| Year-to-Date Return | 20.41% |
|---|---|
| 1-Year Return | 31.62% |
| 3-Year Annualized Return | 1.36% |
| 5-Year Annualized Return | NA% |
| Expense Ratio | 0.48 |
|---|---|
| Net Assets | $ 130 mil |
| Alpha | 0.42 |
| R-Squared | 0.62 |
| Dividend (Yield) | $0.16 (1.52%) |
| Avg. Market Cap | $ 43,750 mil |
| Beta | 0.71 |
| Price/Earnings | 18.25 |
| Ex-Dividend Date | 9/22/2009 |
| Turnover | 27.00 |
| Standard Deviation | 5.12 |
| Price/Book | 3.63 |
| Management Company | Barclays Global Fund Advisors |
| Administrator | Barclays Global Fund Advisors |
| Company of Name | % of Total | # of Shares Held |
|---|---|---|
| 1. Johnson & Johnson | 8.21% | 131,615 |
| 2. Pfizer | 7.55% | 437,766 |
| 3. Merck | 6.76% | 201,910 |
| 4. Wyeth | 6.01% | 121,663 |
| 5. Abbott Laboratories | 5.97% | 127,854 |
| 6. Schering Plough Corp | 5.72% | 196,734 |
| 7. Bristol Myers | 5.41% | 236,696 |
| 8. Allergan Inc | 4.57% | 79,133 |
| 9. Eli Lilly and Co | 4.51% | 130,528 |
| 10. Forest Laboratories Inc | 3.72% | 122,926 |
| % of Total Holdings | 58.43% |